Severe Dengue Epidemics in Sri Lanka, 2003–2006 by Kanakaratne, Nalaka et al.
Recent emergence of dengue hemorrhagic fever in the 
Indian subcontinent has been well documented in Sri Lan-
ka. We compare recent (2003–2006) and past (1980–1997) 
dengue surveillance data for Sri Lanka. The 4 dengue virus 
(DENV) serotypes have been cocirculating in Sri Lanka for 
>30 years. Over this period, a new genotype of DENV-1 has 
replaced an old genotype. Moreover, new clades of DENV-3 
genotype III viruses have replaced older clades. Emergence 
of new clades of DENV-3 in 1989 and 2000 coincided with 
abrupt increases in the number of reported dengue cases, 
implicating this serotype in severe epidemics. In 1980–
1997, most reported dengue cases were in children. Recent 
epidemics have been characterized by many cases in chil-
dren and adults. Changes in local transmission dynamics 
and genetic changes in DENV-3 are likely increasing emer-
gence of severe dengue epidemics in Sri Lanka.
D
engue viruses (DENVs) are mosquito-borne ﬂ  avivi-
ruses that each year infect millions of persons living in 
tropical and subtropical regions of the world. Several hun-
dred thousand of these infections, especially in children, 
progress to a life-threatening disease known as dengue 
hemorrhagic fever (DHF). Dengue has emerged in many 
regions of the world and the number of cases and the range 
of the virus continue to increase every year (1).
The DENV complex consists of 4 distinct serotypes, 
designated DENV-1, DENV-2, DENV-3, and DENV-4. 
Infection with 1 DENV serotype is believed to provide 
long-term immunity to the homologous serotype but not 
to the other serotypes (2). Thus, persons can be infected 
with multiple serotypes during their lifetime. People with 
a repeat (secondary) DENV infection have a greater risk 
for DHF than persons infected for the ﬁ  rst time, indicating 
that preexisting serotype cross-reactive immunity is a risk 
factor for severe disease (3,4). Furthermore, all 4 serotypes 
of DENV can cause DHF, but within each serotype some 
genotypes or clades within genotypes are linked to severe 
disease and others to mild disease (5–7).
Factors driving global emergence of dengue fever 
(DF) and DHF are complex and include viral and host 
factors as well as environmental changes that favor trans-
mission. The epidemiology of dengue in Sri Lanka is 
particularly interesting because before 1989 all 4 sero-
types were present and many repeat infections occurred, 
but few cases of DHF were documented (8,9). Incidence 
of DHF dramatically increased in 1989, and hundreds to 
thousands of cases of DHF have been documented every 
year since (8). Genetic studies with DENV-3 strains from 
Sri Lanka demonstrated that viruses isolated before and 
after emergence of DHF belonged to 2 distinct clades 
(DENV-3, genotype IIIA and IIIB, respectively), indicat-
ing that DENV-3 strain differences are likely to have con-
tributed to emergence of DHF (7).
The magnitude of DF and DHF epidemics in Sri Lanka 
has continued to increase; 2 of the largest epidemics oc-
curred in 2002 and 2004. We report results from dengue 
surveillance and virologic studies conducted during 2003–
2006 in Sri Lanka. We also compare recent (2003–2006) 
and past (1981–1997) surveillance data and virus isolates 
to better understand factors driving emergence of severe 
disease in Sri Lanka.
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Materials and Methods
Sample Collection
Genetech Molecular Diagnostics Institute in Colombo, 
Sri Lanka, receives diagnostic specimens for dengue test-
ing from clinics and hospitals in Colombo. This study used 
excess serum samples that remained after diagnostic test-
ing. Only samples collected from patients with 1–4 days 
of fever were included in the study. All patient-identifying 
information was removed from specimens before their use 
in the study. The study was reviewed and approved by the 
Institutional Review Boards of the University of North 
Carolina, Chapel Hill, NC, USA, and the University of Sri 
Lanka, Peradeniya, Sri Lanka.
National Dengue Data Collected by 
Ministry of Health, 1996–2005
DF and DHF are reportable diseases in Sri Lanka. All 
practicing doctors treating dengue patients are expected to 
report cases to local health ofﬁ  cers, who report cases on a 
weekly basis to the Central Epidemiology Unit of the Min-
istry of Health in Colombo. National data reported in this 
article are based on cases reported to the Central Epidemi-
ology Unit. A special investigation form for collection of 
detailed information is sent out by the Central Epidemiol-
ogy Unit for each reported case of DF or DHF to the re-
porting health ofﬁ  ce and the treating hospital. Age-speciﬁ  c 
disease information in this article was compiled from these 
special investigation forms.
Reverse Transcription–PCR for Detection 
and Serotyping of DENVs
Reverse transcription–PCR was performed by using 
the DV1 and DV3 primer set (10) and the ALD 1 and ALD 
2 primer set (11) in 1 reaction. The DV primers amplify a 
470-bp fragment of the nonstructural protein 3 (NS3) gene 
of all ﬂ  aviviruses (10). The ALD1 and ALD2 primers am-
plify a 229–240-bp product from the 3′ untranslated region 
of all DENVs (11). The DV primers were not as sensitive 
as the ALD primers for detecting dengue infection. How-
ever, the 470-bp fragment ampliﬁ  ed by the DV primers was 
used as the template in a second nested PCR to serotype the 
virus (10).
Isolation of DENV
For virus isolation, 15 μL of serum was mixed with185 
μL of minimal essential medium containing 2% fetal bo-
vine serum and added to C6/36 cells growing in 6-well tis-
sue culture plates. The inoculum was incubated for 1 hour 
at 28°C before adding 2 mL of medium and incubating for 
10 days in a CO2 incubator at 28°C. Cells were tested for 
DENV by staining with monoclonal antibody 4G2, which 
binds to the envelope (E) protein of all 4 DENV serotypes. 
Supernatants were harvested from positive wells and fro-
zen as P1 DENV stocks.
Sequencing and Phylogenetic Analysis of DENV
The P1 stocks were used as a source of RNA for 
sequencing and genotyping viruses. Reverse transcrip-
tion–PCR was performed with different primer pairs 
to amplify selected regions of the genome of DENV-1, 
-2, -3, or -4. For DENV-1, we ampliﬁ  ed a 536-bp seg-
ment at the envelope-NS1 junction by using primers D1F 
2034–2055 (5′-CCTTTTGGTGAGAGCTACATCG-3′) 
and D1R 2570–2551 (5′- ACACACACCCTCCTCCCA-
TG-3′). For DENV-2, we ampliﬁ   ed a 519-bp segment 
at the E-NS1 junction by using primers D2F 2050–2071 
(5′-CCATTCGGAGACAGCTACATCA-3′) and D2R 
2569–2548 (5′-GAGCCTTCTGGATAGCTGAAGC-3′). 
For DENV-3, we ampliﬁ  ed a 1,057-bp segment encom-
passing part of the capsid (C) protein, the premembrane 
(preM) protein, and part of the E protein by using prim-
ers D3F 132–159 (5′- TCAATATGCTGAAACGCGT-
GAGAAACCG-3′) and D3R 1189–1171 (5′- CTCCT-
CAGGCAAAACCGCT-3′). For DENV-4, we ampliﬁ  ed a 
962-bp segment encompassing part of the C protein, preM 
protein, and part of the E protein by using primers D4F 137–
162 (5′-TCAATATGCTGAAACGCGAGAGAACCG 3-′) 
and D4R 1099–1074 (5′-CCACTTCCTTGGCTGTTGT 
CTTGATC-3′).
Puriﬁ  ed PCR products were sent to the University of 
North Carolina–Chapel Hill Genome Analysis Facility. 
Overlapping individual nucleic acid sequences were as-
sembled by using VECTOR NTI (ContigExpress, Bethes-
da, MD, USA). Sequences were aligned and analyzed by 
using ClustalX (www.clustal.org), PAUP* (http://paup.
csit.fsu.edu), PHYLIP (http://evolution.gs.washington.
edu/phylip.html), and MEGA4 (www.megasoftware.net) 
software. All new virus sequences were deposited in Gen-
Bank (online Appendix Table, available from www.cdc.
gov/EID/content/15/2/192-appT.htm) for virus strains and 
sequences used to create the phylogenetic trees.
Results
In January 2003, Genetech Molecular Diagnostics 
Institute in Sri Lanka began to test clinical specimens for 
DENV by PCR. Only samples collected from suspected 
dengue case-patients within the ﬁ  rst 4 days of fever were 
tested. During 2003–2006, a total of 3,833 serum samples 
were received from hospitals and clinics. The number of 
samples tested ranged from 212 in 2003 to 1,686 in 2004 
when Sri Lanka had a large DHF epidemic. Of the 3,833 
samples, 930 (24%) were positive by PCR for DENV. On 
an annual basis, the proportion of positive samples was 39% 
in 2003, 22% in 2004, 18% in 2005, and 32% in 2006.
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Comparison of Dengue Data Collected at 
Genetech with Nationally Reported Data
Figure 1, panel A, shows dengue cases reported to 
the Ministry of Health in Sri Lanka during 1980–2005. 
Cases reported before 1996 are based on passive surveil-
lance and outbreak investigations conducted by the Minis-
try of Health. DF and DHF were designated as reportable 
diseases in 1996, and data obtained since 1996 are based 
on mandatory reporting. Although DENVs were common 
in Sri Lanka and persons there were exposed to multiple 
infections, severe disease was rare before 1989 (8). The 
1990s were characterized by small but regular epidem-
ics of severe disease (Figure 1, panel A) (8). In the period 
since 2000, the magnitude of the epidemics has increased 
further; particularly large epidemics occurred in 2002 and 
2004 (Figure 1, panel A).
Most of the dengue samples tested at Genetech were 
received from private hospitals and clinics in Colombo. Be-
cause dengue is a reportable disease in Sri Lanka, physicians 
are expected to report cases to the Ministry of Health. We 
compared monthly dengue data reported to the Ministry of 
Health from Colombo and data collected at Genetech dur-
ing January 2003–April 2006. Data from Genetech closely 
mirrored cases reported to the Ministry of Health, indicat-
ing that the laboratory at Genetech can serve as a sentinel 
site for monitoring DENV activity in the Colombo region 
(Figure 1, panel B). The peak number of cases observed at 
Genetech preceded reported peaks by ≈1 month (Figure 1, 
panel B); these cases from 2 sources were signiﬁ  cantly cor-
related (correlation coefﬁ  cient 0.80).
Circulating Dengue Serotypes
Of 930 PCR-positive samples collected during 2003–
2006, we serotyped 605 samples by nested PCR. DENV 
serotypes 2 (40%) and type 3 (46%) were common, and 
serotypes 1 (7%) and 4 (7%) were rare. We examined the 
relative abundance of each serotype at monthly intervals 
during October 2003–September 2006 (Figure 2). DENV-2 
and DENV-3 were the dominant serotypes throughout the 
study period. DENV-1 and DENV-4 were also regularly 
isolated but in low numbers. All 4 serotypes were detected 
in 2004 and 2006. In 2005, DENV activity was low and 
DENV-1 was not identiﬁ  ed in samples. These results dem-
onstrate that although all 4 serotypes cocirculate in Sri Lan-
ka, DENV serotypes 2 and 3 are primarily responsible for 
clinically apparent cases.
Age Distribution of Dengue Case-Patients
When the age distribution of dengue-positive case-
patients tested at Genetech during 2003–2006 was ana-
lyzed, we observed 2 peaks: the ﬁ  rst in children <4 years 
of age and the second in adults 20–30 years of age (Figure 
3). The peak of disease in adults was surprising because 
previous studies indicated that dengue transmission in Co-
lombo was high and most adults were likely to be immune 
to infection (8). To further evaluate the peak of disease ob-
served in young adults, we examined the age distribution 
of case-patients reported to the Ministry of Health during 
1996–2006. These data showed a striking change in age 
distribution of dengue case-patients over this 11-year pe-
riod (online Technical Appendix, available from www.cdc.
gov/EID/content/15/2/192-Techapp.pdf). Before 2000, one 
large peak of cases was observed in children and few cases 
were observed for adults. After 2000, two peaks of report-
ed disease were observed for children and young adults. 
Moreover, the mean age of reported DF/DHF cases has in-
creased from 15 in 1996 to ≈25 in 2006.
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Figure 1. A) Dengue cases reported to the Epidemiology Unit, 
Ministry of Health, Sri Lanka (1981–2005). B) Comparison of 
monthly reported data for Colombo and Genetech for 2003–2006. 
Colombo data are based on cases reported to the Ministry of Health 
by hospitals and clinics within the Colombo Municipal Council. 
Genetech data are based on the number of PCR-positive cases 
detected each month. 
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Figure 2. Relative abundance of dengue (DEN) virus serotypes in 
Sri Lanka. DEN-positive serum samples obtained from October 
2003 through September 2006 were serotyped by reverse 
transcription–PCR. Severe Dengue Epidemics in Sri Lanka, 2003–2006
Phylogeny of DENVs
We reported that the DENV-3 strains isolated in Sri 
Lanka before and after the emergence of severe disease 
epidemics belonged to 2 distinct clades (7). To further 
characterize the DENVs responsible for recent epidemics 
in Sri Lanka, we isolated virus from serum samples col-
lected in 2003 and 2004. The C6/36 mosquito cell line 
was inoculated by using serum samples from 220 samples 
that were positive by PCR for DENV. Virus was isolated 
from 181/220 specimens. The 181 isolates consisted of 18 
DENV-1 strains, 76 DENV-2 strains, 64 DENV-3 strains, 
and 23 DENV-4 strains. To identify DENV genotypes that 
have been circulating in this country over the past 3 de-
cades, we sequenced representative isolates from 2003 and 
2004, as well as other isolates from Sri Lanka in our collec-
tion. All virus strains and sequences used for this analysis 
are listed in the online Appendix Table. When grouping 
each DENV serotype into different genotypes, we relied on 
the groups and nomenclature described by Rico-Hesse for 
the 4 serotypes (5). Genotypes are named on the basis of 
country of origin of the earliest isolates and not necessarily 
on current distribution of viruses.
Phylogeny of DENV-1 Strains Collected 
during 1983–2004
DENV-1 has been subdivided into 4 genotypes des-
ignated South Paciﬁ  c, Asia, Thailand, and Africa/America 
(5). We evaluated the position of DENV-1 isolates from 
Sri Lanka within this established phylogeny. These isolates 
used were obtained in 1983, 1984, 1997, 2003, and 2004. A 
498-nt fragment from positions 2056 to 2554 (E/NS1 junc-
tion) was used to create a phylogenetic tree. Results dem-
onstrate that the DENV-1 genotype circulating in Sri Lanka 
has changed over the study period. The 2 isolates from Sri 
Lanka obtained in 1983 and 1984 belonged to the South 
Paciﬁ  c genotype (Figure 4). Sometime during 1984–1997, 
the Africa/America DENV-1 genotype became established 
on Sri Lanka and continued to circulate through 2004; the 
South Paciﬁ  c genotype has not been detected during the 
past 8 years.
Phylogeny of DENV-2 Strains Collected 
during 1981–2004
DENV-2 has been subdivided into 4 genotypes des-
ignated Malaysian/Indian subcontinent, Southeast Asian, 
American, and West African (Sylvatic) (5). The Sri Lankan 
DENV-2 strains in our collection were isolated in 1981, 
1982, 1983, 1984, 1985, 1989, 1990, 1996, 1997, 2003, and 
2004. We sequenced the 239-nt fragment from positions 
2311–2550 (E/NS1 junction) and generated a phylogenetic 
tree by using this sequence and existing sequences in Gen-
Bank from representative DENV-2 strains. All DENV-2 
isolates from Sri Lanka are closely related and belong to 
the Indian subcontinent/Malaysia genotype (Figure 5). 
Moreover, there is no evidence for the recent introduction 
of a DENV-2 strain from outside the island because the 
DENV-2 strains from Sri Lanka are more closely related to 
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Figure 3. Clinically apparent dengue in different age groups in Sri 
Lanka, 2003–2006, Sri Lanka. Because true incidence data were 
not available, relative incidence of dengue infections by age cohort 
was estimated. We used Genetech data and known population of 
Colombo by age, to estimate relative incidence. The age group (>60 
years) with the lowest transmission rate was used as a referent for 
calculating the fold difference between each remaining cohort and 
the referent. 
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Figure 4. Phylogram of dengue serotype 1 viruses (DENV-1) 
from Sri Lanka (SL), 1983–2004, and other DENV-1 viruses. 
The tree is based on a 498-bp fragment for positions 2056–2554 
coding portions of envelope protein and nonstructural protein 1. 
Evolutionary history was inferred by using the minimum-evolution 
method (12). Percentages of replicate trees in which the associated 
taxa clustered in the bootstrap test (1,000 replicates) are shown 
next to the branches (13). Phylogenetic analyses were conducted 
in MEGA4 (14). The tree was rooted by using a DENV-1 sylvatic 
strain. Classiﬁ   cation and naming of different DENV-1 genotypes 
is based on the report by Rico-Hesse (5). Scale bar represents 
number of base substitutions per site. RESEARCH
one another than to any other DENV-2 strain used in this 
analysis.
Phylogeny of DENV-3 Strains Collected 
during 1983–2004
DENV-3 has been divided into 4 genotypes designated 
Southeast Asian/South Paciﬁ  c (I), Thailand (II), Indian sub-
continent (III), and American (IV) (5,15). Previous studies 
have demonstrated that all DENV-3 strains from Sri Lanka 
isolated in the 1980s and 1990s belong to Indian subcon-
tinent genotype (III) (7,15). Within genotype III, DENV3 
strains from Sri Lanka form 2 distinct clades linked to mild 
(IIIA) and severe (IIIB) disease epidemics on the island (7). 
DENV-3 IIIB viruses are most closely related to East Af-
rican strains, which indicates that IIIB viruses linked to se-
vere disease in Sri Lanka are likely to have been introduced 
from East Africa (7). In 1994, a DENV-3 genotype III from 
South Asia or East Africa was also introduced into Latin 
America, where it is now well established and responsible 
for severe disease epidemics (7).
Considering the backdrop of the recent expansion of 
DENV-3 genotype III viruses, we were interested in de-
termining the relationship of DENV-3 genotype III strains 
from Sri Lanka isolated in 2003 and 2004 to other DENV-3 
genotype III viruses currently circulating in Africa, the 
Americas, and the Indian subcontinent. We sequenced the 
966-nt fragment from positions 179–1144 (a portion of C, 
all of preM, and a portion of E) and created a tree by us-
ing our sequences and existing sequences in GenBank from 
representative DENV-3 genotype III strains. The DENV-3 
sequences used were from isolates obtained in Sri Lanka 
in 1983, 1984, 1985, 1989, 1990, 1993, 1994, 1997, 1998, 
2003, and 2004. As demonstrated previously by our group, 
DENV-3 genotype III consists of pre (IIIA)– and post 
(IIIB)–1989 clades from Sri Lanka, as well as Latin Ameri-
can and East African clades (Figure 6) (7). The DENV-3 
strains from Sri Lanka isolated in 2003 and 2004 form a 
new, distinct clade that is closely related but distinct from 
the DENV-3 clade IIIB viruses that were isolated in the 
1990s. This new 2003–2004 clade includes an isolate from 
1993, which strongly suggests that the clade is derived from 
strains that have been on the island for some time.
Phylogeny of DENV-4 Strains Collected 
during 1978–2004
The phylogeny of DENV-4 has not been studied as 
extensively as the other serotypes. This serotype can be 
broadly separated into 2 genotypes designated Southeast 
Asian (I) and Indonesian (II) (5). The Southeast Asian 
genotype strains are primarily from Asia, whereas the In-
donesian group has a broad distribution in Asia and the 
Americas. A 296-nt fragment from positions 787–1083 
(preM/E junction) was used to create a phylogenetic tree. 
DENV-4 strains from Sri Lanka isolated in 1978 and in 
2003–2004 group with the Southeast Asian genotype, 
which indicates that this genotype is established on the is-
land (Figure 7). Two DENV-4 isolates from 1992 belong 
to the Indonesian genotype and likely represent a transient 
introduction (Figure 7).
Discussion
Although dengue has been a problem in the Indian 
subcontinent for at least the past 50 years, the disease and 
its viruses remain incompletely studied in the region (16–
18). Over the past 2 decades, the epidemiology of dengue 
has changed and regular epidemics of DF and DHF have 
been reported in Sri Lanka, India, the Maldive Islands, 
Bangladesh, and Pakistan (8,19–23). We need a better un-
derstanding of the epidemiology of dengue in this region 
to develop and implement effective control programs and 
to most effectively use dengue vaccines that are currently 
in clinical trials.
We have investigated the emergence of DHF in Sri 
Lanka by analyzing samples sent for diagnostic testing to 
the Genetech Research Institute in Colombo. This insti-
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Figure 5. Phylogram of dengue serotype 2 viruses (DENV-2) from 
Sri Lanka (SL), 1981–2004, and other DENV-2 viruses. The tree 
is based on a 239-bp fragment for positions 2311–2550 coding for 
amino acids at the envelope protein/nonstructural protein 1 junction. 
The tree was constructed as described in Figure 4 and was rooted 
by using a DENV-2 sylvatic strain. Classiﬁ   cation and naming of 
different DENV-2 genotypes is based on the report by Rico-Hesse 
(5). Scale bar represents number of base substitutions per site. Severe Dengue Epidemics in Sri Lanka, 2003–2006
tute received 3,833 samples for testing during 2003–2006. 
On an annual basis, the proportion of samples positive for 
dengue was 39% in 2003, 22% in 2004, 18% in 2005, and 
32% in 2006. The low proportion of positive samples in 
2004 and 2005 compared with other years was unexpected 
because one would expect a greater proportion of positive 
cases during an epidemic year such as 2004. During the 
2004 epidemic, there was widespread fear of dengue, and 
indiscriminate testing of fever cases is likely to have led to 
the overall lower proportion of positive cases.
We have demonstrated that all 4 serotypes cocirculate 
in Sri Lanka and were responsible for clinically apparent 
cases detected during 2003–2006. DENV types 2 and 3 were 
responsible for most human cases; types 1 and 4 were rela-
tively rare. DENV types 2 and 3 native to the region may be 
more pathogenic than the other serotypes and thus may be 
recovered more frequently during human surveillance.
Viruses isolated during 1978–2004 were sequenced to 
understand the origin and evolution of DENV in Sri Lanka. 
For DENV-1, isolates obtained in Sri Lanka in the 1980s 
belong to the South Paciﬁ  c genotype, whereas more recent 
isolates belong to the American/African genotype. These 
results indicate that the South Paciﬁ  c genotype of DENV-1 
was replaced after a new introduction of the American/
African genotype of DENV-1. All DENV-2 isolates from 
Sri Lanka belong to a single (Indian subcontinent/ Malay-
sian) genotype. There is no evidence for introduction of 
DENV-2 from other areas because DENV-2 strains from 
Sri Lanka were more related to one another than to any 
other strain used in this analysis. All DENV-3 strains from 
Sri Lanka belonged to genotype III. However, in 1989 and 
again in 2000, the dominant clade of DENV-3 genotype III 
was replaced by a new clade of genotype III (7). In 1989, 
the lineage replacement was most likely caused by the in-
troduction of DENV-3 from outside Sri Lanka. In 2000, the 
dominant lineage of DENV-3 was replaced by a previously 
rare lineage from Sri Lanka. The oldest (1978) and most 
recent isolates of DENV-4 belong to the Southeast Asian 
genotype, which indicates that this genotype is established 
on the island.
Perhaps the most striking feature of the epidemiology 
of dengue in Sri Lanka is the abrupt, stepwise increase in 
the number of severe disease cases in 1989 and again in 
2000. In previous studies, we have highlighted the poten-
tial role of a shift in the circulating clade of DENV-3 from 
genotype IIIA to IIIB in this sudden emergence of severe 
disease in 1989 (7). Recent studies have also demonstrated 
that DENV-3 clade IIIB viruses replicate and disseminate 
better in the vector than clade IIIA viruses (24). This ﬁ  nd-
ing may explain the explosive spread of IIIB and close-
ly related viruses within the region as well as into Latin 
America. The stepwise increase in cases after 2000 was 
accompanied by appearance of another clade of DENV-3 
genotype III viruses that have replaced the clade IIIB virus-
es. Thus, evolution within DENV-3 genotype III continues 
to be linked to changes in disease severity in Sri Lanka. A 
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Figure 6. Phylogram of dengue serotype 3 (DENV-3) genotype 
III viruses from Sri Lanka (SL), 1981–2004, and other DENV-3 
genotype III viruses. The tree is based on a 966-bp fragment for 
positions 179–1144 coding for a portion of the capsid protein, all of 
the premembrane protein, and a portion of the envelope protein. The 
tree was constructed as described in Figure 4 and rooted by using 
a DENV-3 genotype I virus (H87). Naming of the different groups 
within DENV-3 genotype III is based on the report by Messer et al. 
(7). Scale bar represents number of base substitutions per site 
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Figure 7. Phylogram of dengue serotype 4 viruses (DENV-4) from 
Sri Lanka (SL), 1978–2004, and other DENV-4 viruses. The tree is 
based on a 296-bp for positions 787–1083 coding for portions of 
premembrane and envelope proteins. The tree was constructed as 
described in Figure 4 and rooted by using a sylvatic DENV-4 strain. 
Classiﬁ  cation and naming of different DENV-4 genotypes is based 
on the report by Rico-Hesse (5). Scale bar represents number of 
base substitutions per site. RESEARCH
similar phenomenon has also been reported by Bennett et 
al. (25,26). They compared data for 20 years from Puerto 
Rico for DENV-2 and DENV-4 and observed replace-
ment of dominant clades by a previously rare lineage in 
the population or by viruses introduced from outside Puerto 
Rico. Clade replacement was linked to positive selection in 
the NS2A gene for DENV-4 and the E gene for DENV-2. 
Further studies are needed to assess if mutations in spe-
ciﬁ  c genes are also linked to emergence of new clades of 
DENV-3 in Sri Lanka.
When analyzing data collected at Genetech during 
2003–2006, we observed a peak of dengue in young adults 
(20–30 years of age). Analysis of national data collected 
during 1996–2005 demonstrated that the disease peak in 
adults is a recent phenomenon and occurred after 2000. In 
areas with high transmission, where the virus has been his-
torically established, most adults are likely to be immune 
because of childhood infections. The changing age struc-
ture may be indicative of the virus moving into new areas 
with many susceptible adults. During the large epidemics 
that occurred after 2000, many cases were reported from 
regions of the country where few cases have been reported 
(Epidemiology Unit, Ministry of Health, unpub. data). To 
better understand the molecular epidemiology and chang-
ing age distribution of dengue in Sri Lanka, laboratory-
supported, population-based, active surveillance studies 
are needed.
Acknowledgments
Dr Maya Gunasekera, who planned and directed most of the 
work described in this article, died in 2006. She was a pioneer 
who introduced modern molecular biology to Sri Lanka. She 
founded Genetech Research Institute in 2004 to promote objec-
tive-oriented, independent scientiﬁ  c research in the life sciences. 
Her premature death at the age of 44 was a severe loss to the com-
munity of scientists in Sri Lanka. Her co-authors are honored to 
have worked with her.
We thank Duane J. Gubler for providing all isolates of Sri 
Lankan viruses for 1981–1994. 
This study was supported by a National Institutes of Health 
Fogarty International Research Collaborative Award (R03 
TW007319) to A.M.d.S., M.G., and N.K.
Dr Kanakaratne is a member of the Genetech Research Insti-
tute in Colombo, Sri Lanka. His research interests include study 
of emerging viruses and development of novel, cost-effective di-
agnostics for infectious diseases in developing nations.
References
    1.    Mackenzie JS, Gubler DJ, Petersen LR. Emerging ﬂ  aviviruses: 
the spread and resurgence of Japanese encephalitis, West Nile and 
dengue viruses. Nat Med. 2004;10(Suppl):S98–109. DOI: 10.1038/
nm1144
  2.   Innis BL. Antibody responses to dengue virus infection. In: Gubler 
DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. New 
York: CAB International; 1997. p. 221–44.
  3.   Halstead SB. Neutralization and antibody-dependent enhancement 
of dengue viruses. Adv Virus Res. 2003;60:421–67. DOI: 10.1016/
S0065-3527(03)60011-4
  4.   Rothman AL. Dengue: deﬁ  ning protective versus pathologic immu-
nity. J Clin Invest. 2004;113:946–51.
  5.   Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv 
Virus Res. 2003;59:315–41. DOI: 10.1016/S0065-3527(03)59009-1
  6.   Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, de 
Chacon, et al. Dengue virus structural differences that correlate with 
pathogenesis. J Virol. 1999;73:4738–47.
  7.   Messer WB, Gubler DG, Harris E, Sivananthan K, de Silva AM. 
Emergence and global spread of a dengue serotype 3, subtype III 
virus. Emerg Infect Dis. 2003;9:800–9.
  8.   Messer WB, Vitarana UT, Sivananthan K, Elvtigala J, Preethimala 
LD, Ramesh R, et al. Epidemiology of dengue in Sri Lanka before 
and after the emergence of epidemic dengue hemorrhagic fever. Am 
J Trop Med Hyg. 2002;66:765–73.
    9.    Vitarana UT, Jayasekera N, Withane N, Gubler DJ. Finding the 
cause of dengue hemorrhagic fever outbreaks in Sri Lanka. Arbovi-
rus Research in Australia. 1993;6:125–9.
10.   Seah CL, Chow VT, Tan HC, Can YC. Rapid, single-step RT-PCR 
typing of dengue viruses using ﬁ  ve NS3 gene primers. J Virol Meth-
ods. 1995;51:193–200. DOI: 10.1016/0166-0934(94)00104-O
11.   Sudiro TM, Ishiko H, Green S, Vaughn DW, Nisalak A, Kalayana-
rooj S, et al. Rapid diagnosis of dengue viremia by reverse tran-
scriptase-polymerase chain reaction using 3′-noncoding region uni-
versal primers. Am J Trop Med Hyg. 1997;56:424–9.
12.    Rzhetsky A, Nei M. AMETREE: a program package for infer-
ring and testing minimum-evolution trees. Comput Appl Biosci. 
1994;10:409–12.
13.   Felsenstein J. Conﬁ  dence limits on phylogenies: an approach using 
the bootstrap. Evolution Int J Org Evolution. 1985;39:783–91. DOI: 
10.2307/2408678
14.   Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolu-
tionary genetics analysis (MEGA) software version 4.0. Mol Biol 
Evol. 2007;24:1596–9. DOI: 10.1093/molbev/msm092
15.   Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution 
and epidemiology of dengue-3 viruses. J Gen Virol. 1994;75:65–75. 
DOI: 10.1099/0022-1317-75-1-65
16.   Carey DE, Myers RM, Reuben R. Dengue types 1 and 4 viruses 
in wild-caught mosquitoes in south India. Science. 1964;143:131–2. 
DOI: 10.1126/science.143.3602.131
17.   Myers RM, Varkey MJ, Reuben R, Jesudass ES. Dengue outbreak in 
Vellore, southern India, in 1968, with isolation of four dengue types 
from man and mosquitoes. Indian J Med Res. 1970;58:24–30.
18.   Vitarana T. Viral diseases in Sri Lanka: a national overview. In: 
Mackenzie JS, editor. Viral diseases in Southeast Asia and the west-
ern Paciﬁ  c London: Academic Press; 1982. p. 198–204.
19.   Rahman M, Rahman K, Siddque AK, Shoma S, Kamal AH, Ali 
KS, et al. First outbreak of dengue hemorrhagic fever, Bangladesh. 
Emerg Infect Dis. 2002;8:738–40.
20.   Chan YC, Salahuddin NI, Khan J, Tan HC, Seah CL, Li J, et al. Den-
gue haemorrhagic fever outbreak in Karachi, Pakistan, 1994. Trans 
R Soc Trop Med Hyg. 1995;89:619–20. DOI: 10.1016/0035-9203
(95)90412-3
21.   Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, et al. 
Concurrent infections by all four dengue virus serotypes during an 
outbreak of dengue in 2006 in Delhi, India. Virol J. 2008;5:1. DOI: 
10.1186/1743-422X-5-1
22.  Dar L, Broor S, Sengupta S, Xess I, Seth P. The ﬁ  rst major out-
break of dengue hemorrhagic fever in Delhi, India. Emerg Infect 
Dis. 1999;5:589–90.
198  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 2, February 2009Severe Dengue Epidemics in Sri Lanka, 2003–2006
23.   Lucas GN, Amerasinghe A, Sriranganathan S. Dengue haemorrhagic 
fever in Sri Lanka. Indian J Pediatr. 2000;67:503–4. DOI: 10.1007/
BF02760477
24.   Hanley KA, Nelson JT, Schirtzinger EE, Whitehead SS, Hanson CT. 
Superior infectivity for mosquito vectors contributes to competitive 
displacement among strains of dengue virus. BMC Ecol. 2008;8:1. 
DOI: 10.1186/1472-6785-8-1
25.    Bennett SN, Holmes EC, Chirivella M, Rodriguez DM, Beltran 
M, Vorndam V, et al. Selection-driven evolution of emergent den-
gue virus. Mol Biol Evol. 2003;20:1650–8. DOI: 10.1093/molbev/
msg182
26.    Bennett SN, Holmes EC, Chirivella M, Rodriguez DM, Beltran 
M, Vorndam V, et al. Molecular evolution of dengue 2 virus in 
Puerto Rico: positive selection in the viral envelope accompanies 
clade reintroduction. J Gen Virol. 2006;87:885–93. DOI: 10.1099/
vir.0.81309-0
Address for correspondence: Nalaka Kankaratne, Genetech Research 
Institute, 54 Kitulwatte Road, Colombo 8, Sri Lanka; email: genetech@
slt.lk
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 2, February 2009  199 